| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―28 |
Protection of SARS-CoV-2 Infection by Targeting Viral Spike Protein With De Novo Designed ACE2-Derived Undecapeptide |
Anindya Dutta, Nilanjan Banerjee, Soushruti Sarkar, Abhishek Sen, Partha Chakrabarti, Ananya Dutta, et al. (+4) Kuladip Jana, Gopeswar Mukherjee, Samit Chattopadhyay, Subhrangsu Chatterjee |
| 2 |
[GO] |
2023―Nov―30 |
Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay |
James Stewart, Jakaria Shawon, Md Ackas Ali, Blaise Williams, A. D. A. Shahinuzzaman, Sharmin Akther Rupa, et al. (+10) Taha Al-Adhami, Ruoqing Jia, Cole Bourque, Ryan Faddis, Kaylee Stone, Md Abu Sufian, Rajib Islam, Andrew C. McShan, Khondaker Miraz Rahman, Mohammad A. Halim |
| 3 |
[GO] |
2023―Sep―13 |
Chemically modified antiviral peptides against SARS-CoV-2 |
Michael Quagliata, Anna Maria Papini, Paolo Rovero |
| 4 |
[GO] |
2023―Jul―28 |
Antimicrobial peptides for novel antiviral strategies in the current post-COVID-19 pandemic |
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, Bruno Casciaro |
| 5 |
[GO] |
2022―Dec―08 |
SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics? |
Sergio Algar-Lizana, Ma Ángeles Bonache, Rosario González-Muñiz |
| 6 |
[GO] |
2022―Feb―15 |
Stapled peptides as potential inhibitors of SARS-CoV-2 binding to the hACE2 receptor |
Susan Tzotzos |
|
